SEARCH

SEARCH BY CITATION

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

FilenameFormatSizeDescription
eji2760-sup-0001-Suppmat.pdf482K

Figure S1. NOR but not NOD mice mount oral tolarance against GAD286–300.

Figure S2. Representative examples of the ELISPOTS of Fig. 6B and C are shown (Th1 and Th2 cytokine analysis in NOD.

Figure S3. Oral treatment with CTB-2.5mi does not prevent T1D development in NOD mice.

Table S1. referring to Figure 2B: Absolute number of Ag7/2.5mi tetramer+ CD4+ T cells of NOD mice immunized i.p. as indicateda

Table S2. referring to Figure 3A: Absolute numbers of tetramer+ CD4 T cells in NOD mice receiving the indicated type of treatmenta

Table S3. referring to Figure 7: Absolute numbers of tetramer+ CD4 T cells of the indicated subsets receiving the indicated type of treatment a)

eji2760-sup-0002-Suppmat.pdf277KPeer review correspondence

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.